The discovery and development of vandetanib for the treatment of thyroid cancer

By Sim Michael W   Cohen Mark Steven  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 105-114

Informa Healthcare

Access to resources Recommend Favorite

Indication and Timing of Thyroid Surgery for Patients with Hereditary Medullary Thyroid Cancer Syndromes

By Ogilvie Jennifer B.   Kebebew Electron  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 139-147

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Vandetanib for the treatment of lung cancer

By Chu Caleb T   Sada Yvonne H   Kim Edward S  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1211-1221

Informa Healthcare

Access to resources Recommend Favorite

Vandetanib for the treatment of non-small-cell lung cancer

By Wong Hui-li   de Boer Richard H  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2271-2278

Informa Healthcare

Access to resources Recommend Favorite

XL184 (cabozantinib) for medullary thyroid carcinoma

By Durante Cosimo   Russo Diego   Verrienti Antonella   Filetti Sebastiano  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 407-413

Informa Healthcare

Access to resources Recommend Favorite